Form 4: PBH Director Celeste Clark Receives RSU Grant

Prestige Consumer Healthcare Inc. Director Celeste Clark received 2,094 restricted stock units valued at $155,000 as part of the company's director compensation program.

Summary

• Director Celeste A. Clark of Prestige Consumer Healthcare Inc. (PBH) acquired 2,094 shares of common stock.
• The acquisition was in the form of restricted stock units (RSUs) as part of the Issuer's director compensation program.
• The RSUs are valued at $155,000, based on a closing stock price of $74.04 on August 5, 2025.
• Following this transaction, Celeste A. Clark beneficially owns 13,530 shares of common stock.
• The RSUs vest on the first anniversary of the grant date.
• Settlement of the vested RSUs will occur upon the earliest of the reporting person's death, separation from service, or a change in control.

Sentiment

Score: 7

Explanation: The filing reports a routine, expected director equity compensation grant, which is generally viewed positively as it aligns director interests with shareholders. There are no negative or unexpected elements.

Positives

• The grant of restricted stock units aligns the director's interests with long-term shareholder value through equity compensation.
• The compensation program helps attract and retain qualified board members.

Future Outlook

The restricted stock units are scheduled to vest on the first anniversary of the grant date, with settlement occurring upon the earliest of the director's death, separation from service, or a change in control.

Industry Context

This filing is a routine insider transaction related to director compensation, common across publicly traded companies. It does not provide broader industry trends or competitive insights.

Comparison to Industry Standards

• Director compensation programs, including the use of restricted stock units, are standard practice in corporate governance across various industries.
• The specific value and number of units are determined by the company's compensation policies and market rates for director services, but no specific comparable companies or projects are mentioned in the filing.

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with shareholders by tying compensation to stock performance.

Next Steps

• Vesting of the 2,094 restricted stock units on the first anniversary of the grant date (August 5, 2026).
• Settlement of vested restricted stock units upon the earliest of the director's death, separation, or a change in control.

Key Dates

Recommendation

This Form 4 filing details a routine director compensation grant and does not contain information that would fundamentally alter the investment thesis for Prestige Consumer Healthcare Inc. It is a standard operational disclosure and does not suggest a significant change in the company's financial health or strategic direction that would warrant a change in investment recommendation.

Keywords

Prestige Consumer Healthcare, PBH, SEC Form 4, Restricted Stock Units, RSU, Director Compensation, Equity Compensation, Insider Transaction, Celeste Clark